Physicians expanding a telehealth practice into Colorado generally need to think through three separate but related questions: whether a full Colorado license or an alternate registration pathway applies, whether Colorado participates in the Interstate Medical Licensure Compact (IMLC) in a way that fits the physician's situation, and how DEA and state controlled-substance rules layer on top of any medical license held. None of these questions has a single universal answer — the right path depends on practice setting, patient volume, and prescribing needs.
Licensure pathway basics
Most states, including Colorado, distinguish between physicians who are physically located in the state, physicians treating patients located in the state from elsewhere, and physicians providing only occasional or consultative telehealth services. Colorado's medical board sets its own thresholds for what counts as practicing medicine within its borders and what registration or licensure category applies. Because these thresholds are periodically revised, physicians typically confirm current definitions directly with the board rather than relying on prior-year summaries.
Compact eligibility considerations
The IMLC offers an expedited path to licensure in participating states for physicians who meet eligibility criteria, including holding a full and unrestricted license in a state of principal license. Compact membership and the specific requirements for using it can change, so rather than assuming Colorado's current compact status, physicians generally check whether Colorado is a current IMLC member and what documentation the compact commission requires at the time of application.
See current Colorado telehealth requirements →DEA and controlled-substance prescribing
Prescribing controlled substances via telehealth typically involves a second, separate layer of compliance beyond medical licensure. Physicians generally need a DEA registration valid for the state where the patient is located (or an applicable telemedicine exception), and many states layer additional requirements on top of federal rules, such as specific informed consent language or limits on audio-only encounters for certain drug schedules. These rules have been in flux nationally in recent years, so confirming the current federal and state posture before prescribing is typically a standard part of a compliance review.
Informed consent and audio-only care
Many states expect telehealth-specific informed consent, covering topics like the limitations of a remote exam and how follow-up or emergency care will be handled. Audio-only visits are treated differently from video in a number of states, particularly for prescribing purposes. Physicians generally build a checklist of these state-specific expectations before seeing a first patient in a new state.
Licensure, compact eligibility, and DEA prescribing rules are three separate compliance layers — meeting one does not automatically satisfy the others.
Given how frequently these frameworks are updated, this overview is meant as a starting point for orientation rather than a substitute for current guidance. Requirements vary by state and change over time — always confirm current requirements directly with the relevant state board or agency before making a compliance decision.